This component of the program is made possible through Sanofi Cares North America. Hydroxychloroquine (Plaquenil) is considered a disease-modifying anti-rheumatic drug (DMARD). Hydroxychloroquine 200 mg cost Any side effects from stopping plaquenil Pharmacokinetics of chloroquine Financial criteria for patient assistance. In order to meet the financial eligibility criteria for receiving Sanofi medication at no cost, you must have an annual household income of ≤ 400% of the current Federal Poverty Level. Patient Assistance Connection Financial Eligibility for uninsured or functionally uninsured patients Hydroxychloroquine Plaquenil® Sanofi‐Synthelabo Inc. Sanofi Patient Assistance Program 1‐800‐992‐9022 Infliximab Remicade® Centocor, US Remicade Patient Assistance Program 1‐866‐489‐5957 Leflunomide Arava® Sanofi Aventis Sanofi Aventis Pharmaceuticals Patient Assistance Program Call your doctor if you have a prilosec patient assistance program in the amount that you urinate or if you have blood in your urine with is 60 mg of omeprazole too much. Our programs are designed to help qualifying people without insurance, those in Medicare Part D, and those who have faced a financial crisis recently. It may prevent joint damage and reduce the risk of long-term disability. It can decrease the pain and swelling of arthritis. Plaquenil patient assistance program Plaquenil Prices, Coupons & Patient Assistance Programs., Drug Name Brand Name Manufacturer Program Contact. Chloroquine generic Program for Plaquenil. Patient Access Network Foundation PAN. This is a copay assistance program for patients that have health insurance. The patient's. Plaquenil - Patient Assistance Information. Prilosec patient assistance program, prilosec patient.. Rx Outreach Medications - NeedyMeds. Program for Plaquenil. This is a copay assistance program for patients that have health insurance. The patient's insurance must cover the qualifying medication that they are seeking assistance for. Patient with Medicare Part D will be considered on a case by case basis. Patients must be at or below 400-500% of the federal poverty level. Ent Assistance an n in, and adminis I authorize and c the Program. M nosis, if required. as required by la s authorization is this Program. U ay withdraw this in this Program a hereby release, fo ms or liability aris losure is made in nt Assistance rese CTITIONE SS No P. O. NUMBER # INFORMA ge the information meets the require is patient, I. ENBREL. Hydroxychloroquine. Plaquenil®. Sanofi-Synthelabo Inc. Sanofi Patient Assistance Program. 1-800-992-9022. Infliximab Remicade®.